These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32822861)

  • 1. Epigenomic technologies for precision oncology.
    Weichenhan D; Lipka DB; Lutsik P; Goyal A; Plass C
    Semin Cancer Biol; 2022 Sep; 84():60-68. PubMed ID: 32822861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
    Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
    BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Epigenetic Studies in Human Disease: A Primer on -Omic Technologies.
    Yan H; Tian S; Slager SL; Sun Z; Ordog T
    Am J Epidemiol; 2016 Jan; 183(2):96-109. PubMed ID: 26721890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide epigenomic profiling for biomarker discovery.
    Dirks RA; Stunnenberg HG; Marks H
    Clin Epigenetics; 2016; 8():122. PubMed ID: 27895806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaco-epigenomics: On the Road of Translation Medicine.
    López-Camarillo C; Gallardo-Rincón D; Álvarez-Sánchez ME; Marchat LA
    Adv Exp Med Biol; 2019; 1168():31-42. PubMed ID: 31713163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and Precision Oncology.
    Werner RJ; Kelly AD; Issa JJ
    Cancer J; 2017; 23(5):262-269. PubMed ID: 28926426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic alterations in cancer.
    Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in epigenetics and epigenomics for neurodegenerative diseases.
    Qureshi IA; Mehler MF
    Curr Neurol Neurosci Rep; 2011 Oct; 11(5):464-73. PubMed ID: 21671162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell epigenomics: techniques and emerging applications.
    Schwartzman O; Tanay A
    Nat Rev Genet; 2015 Dec; 16(12):716-26. PubMed ID: 26460349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epigenomics of embryonic stem cell differentiation.
    Kraushaar DC; Zhao K
    Int J Biol Sci; 2013; 9(10):1134-44. PubMed ID: 24339734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Getting personal with epigenetics: towards individual-specific epigenomic imputation with machine learning.
    Hawkins-Hooker A; Visonà G; Narendra T; Rojas-Carulla M; Schölkopf B; Schweikert G
    Nat Commun; 2023 Aug; 14(1):4750. PubMed ID: 37550323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promise of epigenetic therapy: reprogramming the cancer epigenome.
    Kelly AD; Issa JJ
    Curr Opin Genet Dev; 2017 Feb; 42():68-77. PubMed ID: 28412585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation.
    Mancarella D; Plass C
    Genome Med; 2021 Feb; 13(1):23. PubMed ID: 33568205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epigenomics of sarcoma.
    Nacev BA; Jones KB; Intlekofer AM; Yu JSE; Allis CD; Tap WD; Ladanyi M; Nielsen TO
    Nat Rev Cancer; 2020 Oct; 20(10):608-623. PubMed ID: 32782366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer Detection.
    Leal A; Sidransky D; Brait M
    Clin Chem; 2020 Jan; 66(1):105-116. PubMed ID: 31843869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypes from cell-free DNA.
    Zukowski A; Rao S; Ramachandran S
    Open Biol; 2020 Sep; 10(9):200119. PubMed ID: 32873154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the cancer epigenome for therapy.
    Jones PA; Issa JP; Baylin S
    Nat Rev Genet; 2016 Sep; 17(10):630-41. PubMed ID: 27629931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
    Cacabelos R
    Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity.
    Hu Y; Shen F; Yang X; Han T; Long Z; Wen J; Huang J; Shen J; Guo Q
    Clin Epigenetics; 2023 Oct; 15(1):161. PubMed ID: 37821906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.